01 — At a Glance
The Conglomerate Where Every Unit Is Playing a Different Game
- 52-Week High / Low₹3,325 / ₹2,314
- Q3 FY26 Revenue₹3,713 Cr
- Q3 FY26 PAT₹433 Cr
- Q3 FY26 EPS₹14.60
- Annualised EPS (9M avg×4)₹56.36
- Book Value₹447
- Price to Book5.86x
- Dividend Yield0.34%
- Debt / Equity0.35x
- TTM Revenue₹15,485 Cr
Auditor’s Opening Note: SRF closed Q3 FY26 with ₹3,713 crore revenue (+6% YoY), ₹433 crore PAT (+60% YoY), but buried inside these numbers are three wildly different businesses: specialty chemicals losing money to Chinese dumping, fluorochemicals on a record-breaking streak thanks to global quota restrictions, and packaging films showing early signs of Chinese competition discipline. The valuation reflects maximum confusion at 42x P/E — which is either a screaming bargain if Odisha’s next-gen refrigerants scale, or a rope if agro deferment persists and China decides to ignore Kigali quotas.
02 — Introduction
Welcome to SRF: The Company Even Management Doesn’t Fully Understand
Listen. SRF is not one company. It’s four companies pretending to be one. It makes refrigerant gases for air conditioners in an environment where global quotas are being enforced. It manufactures specialty chemicals for agrochemical majors who’ve decided to stop buying. It produces plastic films for FMCG packagers who are confused about GST rates. And it weaves industrial fabrics in a world where conveyor belts to the US are facing tariff uncertainties. All at the same time. All under one BSE ticker.
The stock is up 27% in 10 years but down 11% in one year. The P/E is 42x — which is 2.4x the industry median. Yet TTM profit is ₹1,849 crore, growing at 61% annually. The company is consciously sacrificing short-term pricing in specialty chemicals to hold market share against Chinese competitors it believes will eventually collapse under their own margin economics. Management is telling you that Chinese players “cannot sustain these prices… the question is not if, but when” correction happens. They’re betting. You’re paying 42x for the bet. This is either genius or insanity. The earnings call will help you decide which.
Incorporated in 1973, SRF has evolved from a niche technical textiles player to a conglomerate with presence in four business verticals, 16 manufacturing facilities, and export operations in 100+ countries. The company’s character is defined by one thing: long-term capital discipline masquerading as short-term chaos. They’re running a ₹12,300 crore capex cycle to future-proof the portfolio, but the near-term earnings visibility is worse than a monsoon forecast.
Concall Summary (Jan 2026): “PAT +60% YoY” sounds stellar until you learn it’s driven by 73 crore of wage-code exceptional items and 99 crore of favorable tax ITAT orders. Core operational leverage exists. But layering it under one-offs makes it hard to know if growth is real or optical.
03 — Business Model: Four Wars, One Scoreboard
If There’s a Price War, SRF Is Probably In It
EduInvesting runs entirely on reader support — ₹360 a year keeps the lights on.
